SEI Investments’s Aimmune Therapeutics AIMT Stock Holding History

SEI Investments’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,233	Closed	-$456K	–	2581
2020 Q3	$456K	Sell	13,233 -817	-6%	-$17.4K	﹤0.01%	1922
2020 Q2	$234K	Buy	14,050 +3,580	+34%	+$60.8K	﹤0.01%	2182
2020 Q1	$149K	Buy	10,470 +3,609	+53%	+$92.2K	﹤0.01%	2191
2019 Q4	$231K	Buy	+6,861	New	+$192K	﹤0.01%	2238
2019 Q2	–	Sell	-3,120	Closed	-$66K	–	2914
2019 Q1	$66K	Buy	+3,120	New	+$73.5K	﹤0.01%	2571

SEI Investments's AIMT Position: Q4 2020 in Review

SEI Investments sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 13,233 shares — an estimated $456K sold.

SEI Investments first reported a position in AIMT in Q1 2019 and held it in 5 quarters. The position peaked at $456K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

SEI Investments reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
SEI Investments sold 13,233 Aimmune Therapeutics shares in Q4 2020, an estimated $456K.
SEI Investments first reported a position in Aimmune Therapeutics in Q1 2019 and held it in 5 quarters.
SEI Investments's Aimmune Therapeutics position peaked at $456K in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on SEI Investments's 13F filing for Q4 2020, filed 8 Feb 2021.